Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Red~Oneon Apr 14, 2022 8:01pm
374 Views
Post# 34605660

CLAS enrolling now

CLAS enrolling nowCLAS is pleased to announce that it is currently enrolling a new team of paid pumpers going forward to replace the last dismal failures and duplications. The new hires will be expected to have an exaggerated sense of importance, preoccupation of unlimited success, power, brilliance, beauty, or ideal love, need for excessive admiration,
sense of entitlement, exploitative behaviour, demonstration of arrogant and haughty behaviours and/or attitudes, the belief they are special and unique and can only be understood by, or should associate with, other special or high-status people or institutions
Need for excessive admiration is preferred.

Andy Salzman said "We are very excited since this is all part of our new initiatives going forward".





<< Previous
Bullboard Posts
Next >>